RAAV.hPDE6A vector ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
90Retinitis pigmentosa1

90. Retinitis pigmentosa


Clinical trials : 130 Drugs : 180 - (DrugBank : 41) / Drug target genes : 49 - Drug target pathways : 109
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2016-003705-34-DE
(EUCTR)
02/07/201926/11/2018Administration of a genetically modified virus particle in patients with PDE6A-linked retinitis pigmentosaPIGMENT – PDE6A gene therapy for retinitis pigmentosa PDE6A-linked retinitis pigmentosa;Therapeutic area: Diseases [C] - Eye Diseases [C11]Product Name: rAAV.hPDE6A vectorUniversitätsklinikum TübingenNULLAuthorised-recruitment may be ongoing or finished Female: yes
Male: yes
9 Human pharmacology (Phase 1): yes Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): noGermany